Skip to content

Clinical trials

Kidney Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: Czechia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20121
20131
20153
20212
20221
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Eli Lilly and Company2
Tanabe Pharma Corporation2
Anthera Pharmaceuticals1
Dimerix Bioscience Pty Ltd1
HI-Bio, A Biogen Company1
Human Genome Sciences Inc., a GSK Company1
Institute for Clinical and Experimental Medicine1
Institute of Spa and Balneology, public research institution1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases17
Renal Insufficiency, Chronic6
Diabetes Mellitus, Type 24
Urologic Diseases4
Diabetic Nephropathies3
Glomerulonephritis, IGA3
Glomerulonephritis2
Heart Diseases2
Atherosclerosis1
Autoimmune Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.